Moye Pamela M, Chu Pui Shan, Pounds Teresa, Thurston Maria Miller
Department of Pharmacy Practice, Mercer University College of Pharmacy, Atlanta, GA.
Wellstar Atlanta Medical Center, Atlanta, GA.
Am J Health Syst Pharm. 2018 Feb 15;75(4):183-190. doi: 10.2146/ajhp170256.
The results of a study to determine whether pharmacy team-led postdischarge intervention can reduce the rate of 30-day hospital readmissions in older patients with heart failure (HF) are reported.
A retrospective chart review was performed to identify patients 60 years of age or older who were admitted to an academic medical center with a primary diagnosis of HF during the period March 2013-June 2014 and received standard postdischarge follow-up care provided by physicians, nurses, and case managers. The rate of 30-day readmissions in that historical control group was compared with the readmission rate in a group of older patients with HF who were admitted to the hospital during a 15-month intervention period (July 2014-October 2015); in addition to usual postdischarge care, these patients received medication reconciliation and counseling from a team of pharmacists, pharmacy residents, and pharmacy students.
Twelve of 97 patients in the intervention group (12%) and 20 of 80 patients in the control group (25%) were readmitted to the hospital within 30 days of discharge ( = 0.03); 11 patients in the control group (55%) and 7 patients in the intervention group (58%) had HF-related readmissions ( = 0.85).
In a population of older patients with HF, the rate of 30-day all-cause readmissions in a group of patients targeted for a pharmacy team-led postdischarge intervention was significantly lower than the all-cause readmission rate in a historical control group.
报告一项关于确定由药学团队主导的出院后干预措施能否降低老年心力衰竭（HF）患者30天再入院率的研究结果。
进行一项回顾性病历审查，以确定2013年3月至2014年6月期间因原发性HF诊断入住学术医疗中心且接受医生、护士和病例管理人员提供的标准出院后随访护理的60岁及以上患者。将该历史对照组的30天再入院率与15个月干预期（2014年7月至2015年10月）期间入住医院的一组老年HF患者的再入院率进行比较；除常规出院后护理外，这些患者还接受了由一组药剂师、药学住院医师和药学专业学生进行的用药核对和咨询。
干预组97例患者中有12例（12%）在出院后30天内再次入院，对照组80例患者中有20例（25%）再次入院（P = 0.03）；对照组11例患者（55%）和干预组7例患者（58%）因HF再次入院（P = 0.85）。
在老年HF患者群体中，以药学团队主导的出院后干预为目标的一组患者的30天全因再入院率显著低于历史对照组的全因再入院率。
